"MONOCLONAL ANTIBODY HBME-1 USEFULNESS IN DIFFERENTIATION OF BENIGN NEOPLASM AND DIFFERENTIATED THYROID CARCINOMA"

"MONOCLONAL ANTIBODY HBME-1 USEFULNESS IN DIFFERENTIATION OF BENIGN NEOPLASM AND DIFFERENTIATED THYROID CARCINOMA"

Show other versions (1)

HBME-l is an antimesothelial monoclonal antibody that recognizes an unknown antigen on microvilli of mesothelial cells. The antibody is only relatively specific for mesothelium and is used in the differential diagnosis of mesothelioma and adenocarcinoma within the context of an appropriate immuno-hi...

Full description

Bibliographic Details
Main Authors: M. Mokhtari, M. Sadeghi, A. Talebi
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2005-05-01
Series:Acta Medica Iranica
Subjects:
Thyroid lesion
HBME-l
immunostaining
papillary carcinoma
follicular carcinoma
Online Access:http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/740.pdf&manuscript_id=740

Similar Items

Similar Items